Peter Spanogiannopoulos

4.7k total citations · 1 hit paper
20 papers, 1.8k citations indexed

About

Peter Spanogiannopoulos is a scholar working on Molecular Biology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Peter Spanogiannopoulos has authored 20 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Molecular Medicine. Recurrent topics in Peter Spanogiannopoulos's work include Gut microbiota and health (10 papers), Antibiotic Resistance in Bacteria (6 papers) and Bacterial Genetics and Biotechnology (4 papers). Peter Spanogiannopoulos is often cited by papers focused on Gut microbiota and health (10 papers), Antibiotic Resistance in Bacteria (6 papers) and Bacterial Genetics and Biotechnology (4 papers). Peter Spanogiannopoulos collaborates with scholars based in United States, Canada and Cuba. Peter Spanogiannopoulos's co-authors include Peter J. Turnbaugh, Gerard D. Wright, Elizabeth N. Bess, Rachel N. Carmody, Maulik Thaker, Nicholas Waglechner, Jordan E. Bisanz, Kalinka Koteva, Ricardo Medina and Wenliang Wang and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Peter Spanogiannopoulos

19 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism

2016 507 citations Peter Spanogiannopoulos, Elizabeth N. Bess et al. Nature Reviews Microbiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Spanogiannopoulos United States	15	1.1k	286	279	272	259	20	1.8k
Ana Rita Brochado Germany	11	1.5k 1.3×	287 1.0×	310 1.1×	363 1.3×	145 0.6×	15	2.1k
Xiuying Zhang China	29	1.9k 1.7×	373 1.3×	613 2.2×	213 0.8×	176 0.7×	117	3.3k
Yi Xin China	28	1.8k 1.6×	119 0.4×	423 1.5×	445 1.6×	200 0.8×	114	3.0k
F. Jerry Reen Ireland	28	1.3k 1.2×	328 1.1×	84 0.3×	228 0.8×	233 0.9×	79	2.4k
Jawad Ahmed Pakistan	20	685 0.6×	705 2.5×	146 0.5×	262 1.0×	260 1.0×	70	2.2k
M. Nazmul Huda United States	17	837 0.7×	274 1.0×	190 0.7×	320 1.2×	89 0.3×	49	1.6k
Véronique Blanc France	17	1.1k 1.0×	154 0.5×	378 1.4×	422 1.6×	284 1.1×	39	1.9k
Yuqian Jia China	19	516 0.5×	474 1.7×	55 0.2×	134 0.5×	137 0.5×	25	1.2k
Siegrid De Baere Belgium	31	668 0.6×	138 0.5×	102 0.4×	95 0.3×	593 2.3×	126	3.2k

Countries citing papers authored by Peter Spanogiannopoulos

Since Specialization

Citations

This map shows the geographic impact of Peter Spanogiannopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Spanogiannopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Spanogiannopoulos more than expected).

Fields of papers citing papers by Peter Spanogiannopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Spanogiannopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Spanogiannopoulos. The network helps show where Peter Spanogiannopoulos may publish in the future.

Co-authorship network of co-authors of Peter Spanogiannopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Spanogiannopoulos. A scholar is included among the top collaborators of Peter Spanogiannopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Spanogiannopoulos. Peter Spanogiannopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kyaw, Than S., C. Anders Olson, Cecilia Noecker, et al.. (2025). Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity. Science Translational Medicine. 17(794). eadq8870–eadq8870. 2 indexed citations

Pieper, Lindsey M., Peter Spanogiannopoulos, Regan Volk, et al.. (2023). The global anaerobic metabolism regulator fnr is necessary for the degradation of food dyes and drugs by Escherichia coli. mBio. 14(5). e0157323–e0157323. 3 indexed citations

Spanogiannopoulos, Peter, Than S. Kyaw, Patrick H. Bradley, et al.. (2022). Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism. Nature Microbiology. 7(10). 1605–1620. 64 indexed citations

Schwartzenberg, Reiner Jumpertz von, Jordan E. Bisanz, Svetlana Lyalina, et al.. (2021). Caloric restriction disrupts the microbiota and colonization resistance. Nature. 595(7866). 272–277. 150 indexed citations

Lam, Kathy N., Peter Spanogiannopoulos, Margaret Alexander, et al.. (2021). Phage-delivered CRISPR-Cas9 for strain-specific depletion and genomic deletions in the gut microbiome. Cell Reports. 37(5). 109930–109930. 100 indexed citations

Lam, Kathy N., Peter Spanogiannopoulos, Margaret Alexander, et al.. (2021). Phage-Delivered CRISPR-Cas9 for Strain-Specific Depletion and Genomic Deletions in the Gut Microbiome. SSRN Electronic Journal. 1 indexed citations

Surette, Matthew D., Peter Spanogiannopoulos, & Gerard D. Wright. (2021). The Enzymes of the Rifamycin Antibiotic Resistome. Accounts of Chemical Research. 54(9). 2065–2075. 31 indexed citations

Zou, Ling, Peter Spanogiannopoulos, Lindsey M. Pieper, et al.. (2020). Bacterial metabolism rescues the inhibition of intestinal drug absorption by food and drug additives. Proceedings of the National Academy of Sciences. 117(27). 16009–16018. 41 indexed citations

Bess, Elizabeth N., Jordan E. Bisanz, Fauna Yarza, et al.. (2019). Genetic basis for the cooperative bioactivation of plant lignans by Eggerthella lenta and other human gut bacteria. Nature Microbiology. 5(1). 56–66. 74 indexed citations

10.

Carmody, Rachel N., Jordan E. Bisanz, Benjamin P. Bowen, et al.. (2019). Cooking shapes the structure and function of the gut microbiome. Nature Microbiology. 4(12). 2052–2063. 114 indexed citations

11.

Bisanz, Jordan E., Peter Spanogiannopoulos, Lindsey M. Pieper, Annamarie E. Bustion, & Peter J. Turnbaugh. (2018). How to Determine the Role of the Microbiome in Drug Disposition. Drug Metabolism and Disposition. 46(11). 1588–1595. 38 indexed citations

12.

Spanogiannopoulos, Peter & Peter J. Turnbaugh. (2018). Broad collateral damage of drugs against the gut microbiome. Nature Reviews Gastroenterology & Hepatology. 15(8). 457–458. 13 indexed citations

13.

Spanogiannopoulos, Peter, et al.. (2018). The Metabolism of Fluoropyrimidine Anticancer Drugs by the Human Gut Microbiome. The FASEB Journal. 32(S1).

14.

Stogios, P.J., Georgina Cox, Peter Spanogiannopoulos, et al.. (2016). Rifampin phosphotransferase is an unusual antibiotic resistance kinase. Nature Communications. 7(1). 11343–11343. 47 indexed citations

15.

Spanogiannopoulos, Peter, Elizabeth N. Bess, Rachel N. Carmody, & Peter J. Turnbaugh. (2016). The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nature Reviews Microbiology. 14(5). 273–287. 507 indexed citations breakdown →

16.

Spanogiannopoulos, Peter, Nicholas Waglechner, Kalinka Koteva, & Gerard D. Wright. (2014). A rifamycin inactivating phosphotransferase family shared by environmental and pathogenic bacteria. Proceedings of the National Academy of Sciences. 111(19). 7102–7107. 62 indexed citations

17.

Thaker, Maulik, Wenliang Wang, Peter Spanogiannopoulos, et al.. (2013). Identifying producers of antibacterial compounds by screening for antibiotic resistance. Nature Biotechnology. 31(10). 922–927. 173 indexed citations

18.

Stogios, P.J., Peter Spanogiannopoulos, E. Evdokimova, et al.. (2013). Structure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistance. Biochemical Journal. 454(2). 191–200. 41 indexed citations

19.

Spanogiannopoulos, Peter, Maulik Thaker, Kalinka Koteva, Nicholas Waglechner, & Gerard D. Wright. (2012). Characterization of a Rifampin-Inactivating Glycosyltransferase from a Screen of Environmental Actinomycetes. Antimicrobial Agents and Chemotherapy. 56(10). 5061–5069. 41 indexed citations

20.

Thaker, Maulik, Peter Spanogiannopoulos, & Gerard D. Wright. (2009). The tetracycline resistome. Cellular and Molecular Life Sciences. 67(3). 419–431. 277 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact